DRW Securities’s United Therapeutics UTHR Stock Holding History

DRW Securities’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-8,000	Closed	-$1.08M	–	105
2017 Q1	$1.08M	Buy	+8,000	New	+$1.21M	0.19%	24

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

DRW Securities's UTHR Position: Q1 2026 in Review

DRW Securities sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 781 shares — an estimated $381K sold.

DRW Securities first reported a position in UTHR in Q1 2017 and held it in 3 quarters. The position peaked at $812K in Q1 2017. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

DRW Securities reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
DRW Securities sold 781 United Therapeutics shares in Q1 2026, an estimated $381K.
DRW Securities first reported a position in United Therapeutics in Q1 2017 and held it in 3 quarters.
DRW Securities's United Therapeutics position peaked at $812K in Q1 2017.
850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.